SCHEMBL3341807

SCHEMBL3341807

O=c1[nH]c2ccccc2n2c(Cl)c(Cl)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 3/20 0.56
MGAM O43451 3/20 0.56
PLA2G2A P14555 3/20 0.56
PLA2G5 P39877 3/20 0.56
PLA2G12A Q9BZM1 3/20 0.56
PARP1 P09874 1/20 0.49
MAP4K4 O95819 1/20 0.48
TAOK1 Q7L7X3 1/20 0.48
PBK Q96KB5 1/20 0.48
SLK Q9H2G2 1/20 0.48
ADORA3 P0DMS8 2/20 0.45
HSP90AA1 P07900 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
KDM4E B2RXH2 2/20 0.43
POLB P06746 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
G6PD P11413 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343833 0.76 GRIA1 (0.44) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL3335072 0.76 PLA2G10 (0.58) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL3338398 0.75 PLA2G10 (0.51) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL23869965 0.72 CDC25B (0.72) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL3339022 0.72 PARP1 (0.54) PARP1HSP90AA1RXFP1KDM4EALDH1A1
SCHEMBL30273097 0.69 PARP1 (0.51) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL3337877 0.69 PARP1 (0.51) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL30273108 0.69 ADORA3 (0.48) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL3339042 0.67 PDE2A (0.47) PLA2G10MGAMPLA2G2APLA2G5PLA2G12A
SCHEMBL7323765 0.66 KMT2A (0.56) PARP1KDM4EALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) PARP1, PARP2, PARP4 PLA2G10 4343/4885MGAM 4084/4885PLA2G2A 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.